4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-24-000049
Options or other derivatives
- EVP, Chief Business Officer acquired 41,825 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Baroldi Joseph · EVP, Chief Business Officer
Table II: Derivative
4 lines| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-15 | Grant or award : show line 1 in the form Performance Restricted Stock Units | +17,000 | $0.00 | 17,000 | 29,290 | D |
| 2024-01-15 | Grant or award : show line 2 in the form Restricted Stock Unit | +20,400 | $0.00 | 20,400 | 67,661 | D |
| 2024-01-15 | Grant or award : show line 3 in the form Restricted Stock Unit | +1,800 | $0.00 | 1,800 | 5,762 | I |
| 2024-01-15 | Grant or award : show line 4 in the form Restricted Stock Unit | +2,625 | $0.00 | 2,625 | 8,387 | I |
Loading xslF345X05/edgardoc.xml…